Lippiello PM[au] - Search Results

Year	Number of Results
1979	1
1981	1
1983	1
1985	1
1986	1
1987	1
1988	1
1989	1
1990	1
1991	1
1992	1
1994	1
1995	4
1996	4
1998	1
2000	1
2005	1
2006	1
2007	1
2008	2
2009	6
2010	4
2011	3
2012	6
2013	4
2022	0

1

Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases.

Bencherif M, Lippiello PM, Lucas R, Marrero MB. Bencherif M, et al. Among authors: lippiello pm. Cell Mol Life Sci. 2011 Mar;68(6):931-49. doi: 10.1007/s00018-010-0525-1. Epub 2010 Oct 15. Cell Mol Life Sci. 2011. PMID: 20953658 Free PMC article. Review.

2

Application of alpha7 nicotinic acetylcholine receptor agonists in inflammatory diseases: an overview.

Marrero MB, Bencherif M, Lippiello PM, Lucas R. Marrero MB, et al. Among authors: lippiello pm. Pharm Res. 2011 Feb;28(2):413-6. doi: 10.1007/s11095-010-0283-7. Epub 2010 Sep 22. Pharm Res. 2011. PMID: 20859658 Review.

3

TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity.

Lippiello PM, Beaver JS, Gatto GJ, James JW, Jordan KG, Traina VM, Xie J, Bencherif M. Lippiello PM, et al. CNS Neurosci Ther. 2008 Winter;14(4):266-77. doi: 10.1111/j.1755-5949.2008.00054.x. CNS Neurosci Ther. 2008. PMID: 19040552 Free PMC article. Review.

4

Alpha7 neuronal nicotinic receptors as targets for novel therapies to treat multiple domains of schizophrenia.

Kucinski AJ, Stachowiak MK, Wersinger SR, Lippiello PM, Bencherif M. Kucinski AJ, et al. Among authors: lippiello pm. Curr Pharm Biotechnol. 2011 Mar 1;12(3):437-48. doi: 10.2174/138920111794480589. Curr Pharm Biotechnol. 2011. PMID: 21133847 Review.

5

Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance.

Buccafusco JJ, Letchworth SR, Bencherif M, Lippiello PM. Buccafusco JJ, et al. Among authors: lippiello pm. Trends Pharmacol Sci. 2005 Jul;26(7):352-60. doi: 10.1016/j.tips.2005.05.007. Trends Pharmacol Sci. 2005. PMID: 15946748 Review.

6

Anticholinergic therapy for overactive bladder: a nicotinic modality?

Toler SM, Yohannes D, Lippiello PM, Chancellor MB. Toler SM, et al. Among authors: lippiello pm. Med Hypotheses. 2013 Sep;81(3):456-8. doi: 10.1016/j.mehy.2013.06.008. Epub 2013 Jul 5. Med Hypotheses. 2013. PMID: 23834857

7

Alpha7 nicotinic cholinergic neuromodulation may reconcile multiple neurotransmitter hypotheses of schizophrenia.

Bencherif M, Stachowiak MK, Kucinski AJ, Lippiello PM. Bencherif M, et al. Among authors: lippiello pm. Med Hypotheses. 2012 May;78(5):594-600. doi: 10.1016/j.mehy.2012.01.035. Epub 2012 Feb 13. Med Hypotheses. 2012. PMID: 22336089

8

Functional and structural interaction of (-)-reboxetine with the human α4β2 nicotinic acetylcholine receptor.

Arias HR, Fedorov NB, Benson LC, Lippiello PM, Gatto GJ, Feuerbach D, Ortells MO. Arias HR, et al. Among authors: lippiello pm. J Pharmacol Exp Ther. 2013 Jan;344(1):113-23. doi: 10.1124/jpet.112.197905. Epub 2012 Sep 25. J Pharmacol Exp Ther. 2013. PMID: 23010362

9

Validation of a high-throughput, automated electrophysiology platform for the screening of nicotinic agonists and antagonists.

Graef JD, Benson LC, Sidach SS, Wei H, Lippiello PM, Bencherif M, Fedorov NB. Graef JD, et al. Among authors: lippiello pm. J Biomol Screen. 2013 Jan;18(1):116-27. doi: 10.1177/1087057112457414. Epub 2012 Sep 6. J Biomol Screen. 2013. PMID: 22960782

10

Slice XVIvo™: a novel electrophysiology system with the capability for 16 independent brain slice recordings.

Graef JD, Wei H, Lippiello PM, Bencherif M, Fedorov N. Graef JD, et al. Among authors: lippiello pm. J Neurosci Methods. 2013 Jan 30;212(2):228-33. doi: 10.1016/j.jneumeth.2012.10.009. Epub 2012 Oct 23. J Neurosci Methods. 2013. PMID: 23099344

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results